Allergy and Immunology · West Palm Beach, FL
NPI
1497748123
Since 2005
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1411 N Flagler Dr, Suite #6100
West Palm Beach, FL, 33401
Phone (561) 655-4450
Groups this clinician bills Medicare through
Medicare paid, 2024
$312K
24,195 services
Medicare patients, 2024
438
Average age 75
Drug cost, 2024
$1.9M
1,572 prescriptions
Company payments, 2025
$169
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Clive E Roberson was code 95165 (treatment - miscellaneous), 7,694 times for 105 patients. In total Clive E Roberson billed 24,195 services in 29 codes, and Medicare paid $312K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95165 Treatment - Miscellaneous | Office | 7,694 | 105 | $11.25 | $87K |
| 95004 Test - Miscellaneous | Office | 7,200 | 99 | $3.00 | $22K |
| 95117 Treatment - Miscellaneous | Office | 2,356 | 196 | $8.96 | $21K |
| 95024 Test - Miscellaneous | Office | 1,797 | 80 | $6.34 | $11K |
| 95044 Test - Miscellaneous | Office | 876 | 33 | $3.71 | $3,247 |
| 99213 Office E&M - Established | Office | 316 | 136 | $67.98 | $21K |
| 95018 Test - Miscellaneous | Office | 241 | 19 | $15.74 | $3,794 |
| 99214 Office E&M - Established | Office | 240 | 171 | $90.27 | $22K |
| 95115 Treatment - Miscellaneous | Office | 202 | 25 | $7.01 | $1,417 |
| 95170 Treatment - Miscellaneous | Office | 174 | 11 | $7.86 | $1,368 |
| 96401 Chemotherapy Administration | Office | 171 | 32 | $52.80 | $9,029 |
| 99204 Office E&M - New | Office | 138 | 138 | $120.23 | $17K |
| 95147 Treatment - Miscellaneous | Office | 131 | 12 | $48.55 | $6,361 |
| 94060 Pulmonary Function Testing | Office | 99 | 78 | $28.91 | $2,863 |
| 94726 Pulmonary Function Testing | Office | 86 | 66 | $44.06 | $3,789 |
By year: 2022 $321K for 24,868 services; 2023 $308K for 23,090 services; 2024 $312K for 24,195 services.
Medicare prescription drug claims, 2024
In 2024, the drug Clive E Roberson prescribed most often to Medicare patients was Montelukast Sodium, with 207 prescriptions and refills. In total Clive E Roberson wrote 1,572 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 207 | 379 | 77 | $1,882 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 111 | 122 | 48 | $2,364 |
| Xolair Omalizumab | 88 | 88 | 12 | $316K |
| Flunisolide Generic | 87 | 121 | 49 | $4,109 |
| Ipratropium Bromide Generic | 84 | 131 | 43 | $2,407 |
| Prednisone Generic | 81 | 81 | 63 | $173 |
| Levocetirizine Dihydrochloride Generic | 79 | 137 | 27 | $2,985 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 77 | 91 | 19 | $57K |
| Fluticasone Propionate Generic | 68 | 115 | 28 | $935 |
| Azelastine Hcl Generic | 57 | 96 | 23 | $2,180 |
| Breo Ellipta Fluticasone/Vilanterol | 42 | 54 | Under 11 | $20K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 40 | 50 | 14 | $3,445 |
| Dupixent Syringe Dupilumab | 38 | 38 | Under 11 | $137K |
| Spiriva Respimat Tiotropium Bromide | 26 | 26 | Under 11 | $13K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 24 | 38 | 11 | $3,899 |
Brand drugs: 562 claims; generic drugs: 1,010 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Clive E Roberson $169 ($169 in general payments such as food, travel and fees) from 5 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $58.66.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.